4/A//SEC Filing
Cobuzzi Robert Joseph Jr. 4/A
Accession 0001437749-22-002263
CIK 0001053691other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 8:18 PM ET
Size
9.5 KB
Accession
0001437749-22-002263
Insider Transaction Report
Form 4/AAmended
Cobuzzi Robert Joseph Jr.
Chief Operating Officer
Transactions
- Disposition to Issuer
Common Stock
2021-11-01−6,049→ 24,301 total - Exercise/Conversion
Restricted Stock Unit
2021-11-01−16,350→ 81,750 total→ Common Stock (16,350 underlying) - Exercise/Conversion
Common Stock
2021-11-01+16,350→ 30,350 total
Footnotes (1)
- [F1]On November 1, 2021 (the "Vesting Date"), in connection with the vesting of previously awarded restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a "Share"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the "Plan") and the terms of the underlying award agreement, (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45. The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeother
Related Parties
1- filerCIK 0001799838
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 8:18 PM ET
- Size
- 9.5 KB